Tools

LEADER 03641nam a2200613 i 4500

001 on1442018742;

003 OCoLC;

005 20240729154520.0;

006 m o d f ;

007 cr b|||||a||||;

008 240624s2024 dcu ob f000 0 eng c;

024 8 a| 55-668q| (GPO jacket number);

035 a| (Sirsi) o1442018742;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:118-31;

088 a| Serial no. 118-31 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Antimicrobial resistance :b| examining an emerging public health threat : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, April 28, 2023.;

246 3 a| Examining an emerging public health threat;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2024.;

300 a| 1 online resource (v, 118 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Serial no. 118-31.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Mary Denigan-Macauley, Ph.D., Director, Health Care, Government Accountability Office; Kevin Outterson, Austin B. Fletcher Professor, Boston University School of Law, and Executive Director, CARB-X; Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America; Amy J. Mathers, M.D., Associate Director of Clinical Microbiology and Associate Professor of Medicine and Pathology, University of Virginia School of Medicine.;

518 a| Date of hearing: 2023-04-28.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed June 24, 2024).;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

650 0 a| Drug resistance in microorganismsz| United Statesx| Prevention.=| ^A718;

650 0 a| Antibioticsx| Researchz| United States.=| ^A2142;

650 0 a| Bacterial diseasesx| Treatment.=| ^A6074;

650 0 a| Bacterial diseasesx| Prevention.=| ^A6074;

650 0 a| Biosecurityz| United States.=| ^A1057552;

650 0 a| Health risk assessmentz| United States.=| ^A226628;

650 0 a| Epidemicsz| United Statesx| Prevention.=| ^A48912;

650 0 a| Emergency medical servicesz| United Statesx| Planning.=| ^A5969;

650 0 a| Biological weaponsx| Risk assessmentz| United States.=| ^A261589;

650 0 a| Bioterrorismz| United Statesx| Prevention.=| ^A463533;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.t| Antimicrobial resistancew| (OCoLC)1441808141;

856 40 u| https://purl.fdlp.gov/GPO/gpo2305307| 0;

922 a| BIBCONEWb| 20240624;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6390939;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6390939-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 7/12/2024x| EDOCUMENTz| JERESOURCE;

Antimicrobial resistance : examining an emerging public health threat : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, April 28, 2023.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2024.
Description	1 online resource (v, 118 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo230530
Subjects	Drug resistance in microorganisms--United States. --Prevention. Antibiotics--Research. --United States. Bacterial diseases--Treatment. Bacterial diseases--Prevention. Biosecurity--United States. Health risk assessment--United States. Epidemics--United States. --Prevention. Emergency medical services--United States. --Planning. Biological weapons--Risk assessment. --United States. Bioterrorism--United States. --Prevention.

Variant title	Examining an emerging public health threat
General note	"Serial no. 118-31."
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Mary Denigan-Macauley, Ph.D., Director, Health Care, Government Accountability Office; Kevin Outterson, Austin B. Fletcher Professor, Boston University School of Law, and Executive Director, CARB-X; Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America; Amy J. Mathers, M.D., Associate Director of Clinical Microbiology and Associate Professor of Medicine and Pathology, University of Virginia School of Medicine.
Date/time/place of a event note	Date of hearing: 2023-04-28.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed June 24, 2024).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Antimicrobial resistance
Genre/form	Legislative hearings.
Standard identifier#	55-668 (GPO jacket number)
Technical rpt number	Serial no. 118-31 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:118-31

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Antimicrobial resistance : examining an emerging public health threat : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, April 28, 2023.

Click here for more information about this title

Availability